lobbying_activities: 2959707

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2959707	1622b3fe-0fac-4cee-9f4b-e0f2ec935cba	Q1	TIBER CREEK GROUP	20744	BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)	2023	first_quarter	MMM	Issues related to drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169), Subtitle B (Part B and D drug pricing).	HOUSE OF REPRESENTATIVES,SENATE	70000		0	0	2023-04-14T16:00:28-04:00